Riobaldo M.R. Cintra

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

Andrei C. Spósito, Íkaro Breder, Alexandre Soares et al. · Cardiovascular Diabetology · 2021 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal

Andrei C. Spósito, Luiz Sérgio Fernandes de Carvalho, Riobaldo M.R. Cintra et al. · Atherosclerosis · 2009 · 69 citations

Medicine, Cardiology, Pharmacology +16

Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients

Filipe A. Moura, Valéria Nasser Figueiredo, Bruna Stefany Bento de Sousa Teles et al. · Atherosclerosis · 2015 · 23 citations

Medicine, Hematology, Internal Medicine +11

Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clamp

Filipe A. Moura, Luiz Sérgio Fernandes de Carvalho, Riobaldo M.R. Cintra et al. · American Journal of Physiology-Endocrinology and Metabolism · 2013 · 20 citations

Medicine, Cardiology, Internal Medicine +17

Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial

Riobaldo M.R. Cintra, Alexandre Soares, Íkaro Breder et al. · Diabetology & Metabolic Syndrome · 2019 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17